Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States
We combined American Community Survey data with age-specific Trypanosoma cruzi prevalence derived from US surveys and World Health Organization reports to yield estimates of Chagas disease in the United States, which we mapped at the local level. In addition, we used blood donor data to estimate the relative prevalence of autochthonous T. cruzi infection. Our estimates indicate that 288,000 infected persons, including 57,000 Chagas cardiomyopathy patients and 43,000 infected reproductive-age women, currently live in the United States; 22-108 congenital infections occur annually. We estimated ≈10,000 prevalent cases of locally acquired T. cruzi infection. Mapping shows marked geographic heterogeneity of T. cruzi prevalence and illness. Reliable demographic and geographic data are key to guiding prevention and management of Chagas disease. Population-based surveys in high prevalence areas could improve the evidence base for future estimates. Knowledge of the demographics and geographic distribution of affected persons may aid practitioners in recognizing Chagas disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Emerging infectious diseases - 28(2022), 7 vom: 22. Juli, Seite 1313-1320 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Irish, Amanda [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chagas disease |
---|
Anmerkungen: |
Date Completed 24.06.2022 Date Revised 16.07.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.3201/eid2807.212221 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM34252206X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM34252206X | ||
003 | DE-627 | ||
005 | 20231226014317.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3201/eid2807.212221 |2 doi | |
028 | 5 | 2 | |a pubmed24n1141.xml |
035 | |a (DE-627)NLM34252206X | ||
035 | |a (NLM)35731040 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Irish, Amanda |e verfasserin |4 aut | |
245 | 1 | 0 | |a Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.06.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We combined American Community Survey data with age-specific Trypanosoma cruzi prevalence derived from US surveys and World Health Organization reports to yield estimates of Chagas disease in the United States, which we mapped at the local level. In addition, we used blood donor data to estimate the relative prevalence of autochthonous T. cruzi infection. Our estimates indicate that 288,000 infected persons, including 57,000 Chagas cardiomyopathy patients and 43,000 infected reproductive-age women, currently live in the United States; 22-108 congenital infections occur annually. We estimated ≈10,000 prevalent cases of locally acquired T. cruzi infection. Mapping shows marked geographic heterogeneity of T. cruzi prevalence and illness. Reliable demographic and geographic data are key to guiding prevention and management of Chagas disease. Population-based surveys in high prevalence areas could improve the evidence base for future estimates. Knowledge of the demographics and geographic distribution of affected persons may aid practitioners in recognizing Chagas disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Chagas disease | |
650 | 4 | |a Trypanosoma cruzi | |
650 | 4 | |a United States | |
650 | 4 | |a epidemiology | |
650 | 4 | |a parasites | |
700 | 1 | |a Whitman, Jeffrey D |e verfasserin |4 aut | |
700 | 1 | |a Clark, Eva H |e verfasserin |4 aut | |
700 | 1 | |a Marcus, Rachel |e verfasserin |4 aut | |
700 | 1 | |a Bern, Caryn |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Emerging infectious diseases |d 1995 |g 28(2022), 7 vom: 22. Juli, Seite 1313-1320 |w (DE-627)NLM088704254 |x 1080-6059 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2022 |g number:7 |g day:22 |g month:07 |g pages:1313-1320 |
856 | 4 | 0 | |u http://dx.doi.org/10.3201/eid2807.212221 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2022 |e 7 |b 22 |c 07 |h 1313-1320 |